Effect of Mercury on Membrane Proteins, Anionic Transport and Cell Morphology in Human Erythrocytes.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
21 Sep 2022
Historique:
accepted: 03 09 2022
entrez: 20 9 2022
pubmed: 21 9 2022
medline: 24 9 2022
Statut: ppublish

Résumé

Mercury (Hg) is a heavy metal widespread in all environmental compartments as one of the most hazardous pollutants. Human exposure to this natural element is detrimental for several cellular types including erythrocytes (RBC) that accumulate Hg mainly bound to the SH groups of different cellular components, including protein cysteine residues. The cellular membrane represents a major target of Hg-induced damage in RBC with loss of physiological phospholipid asymmetry, due to phosphatidylserine (PS) exposure to the external membrane leaflet. To investigate Hg-induced cytotoxicity at the molecular level, the possible interaction of this heavy metal with RBC membrane proteins was investigated. Furthermore, Hg-induced alterations in band 3 protein (B3p) transport function, PS-exposing macrovesicle (MVs) formation and morphological changes were assessed. For this aim, human RBC were treated in vitro with different HgCl Findings presented in this paper indicate that RBC exposure to HgCl Altogether, the findings reported in this paper confirm that RBC are particularly vulnerable to Hg toxic effect and provide new insight in the Hg-induced protein modification in human RBC affecting the complex biological system of cellular membrane. In particular, Hg could induce dismantle of vertical cohesion between the plasma membrane and cytoskeleton as well as destabilization of lateral linkages of functional domains. Consequently, decreased membrane deformability could impair RBC capacity to deal with the shear forces in the circulation increasing membrane fragmentations. Furthermore, findings described in this paper have also significant implication in RBC physiology, particularly related to gas exchanges.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
Mercury (Hg) is a heavy metal widespread in all environmental compartments as one of the most hazardous pollutants. Human exposure to this natural element is detrimental for several cellular types including erythrocytes (RBC) that accumulate Hg mainly bound to the SH groups of different cellular components, including protein cysteine residues. The cellular membrane represents a major target of Hg-induced damage in RBC with loss of physiological phospholipid asymmetry, due to phosphatidylserine (PS) exposure to the external membrane leaflet. To investigate Hg-induced cytotoxicity at the molecular level, the possible interaction of this heavy metal with RBC membrane proteins was investigated. Furthermore, Hg-induced alterations in band 3 protein (B3p) transport function, PS-exposing macrovesicle (MVs) formation and morphological changes were assessed.
METHODS METHODS
For this aim, human RBC were treated in vitro with different HgCl
RESULTS RESULTS
Findings presented in this paper indicate that RBC exposure to HgCl
CONCLUSION CONCLUSIONS
Altogether, the findings reported in this paper confirm that RBC are particularly vulnerable to Hg toxic effect and provide new insight in the Hg-induced protein modification in human RBC affecting the complex biological system of cellular membrane. In particular, Hg could induce dismantle of vertical cohesion between the plasma membrane and cytoskeleton as well as destabilization of lateral linkages of functional domains. Consequently, decreased membrane deformability could impair RBC capacity to deal with the shear forces in the circulation increasing membrane fragmentations. Furthermore, findings described in this paper have also significant implication in RBC physiology, particularly related to gas exchanges.

Identifiants

pubmed: 36126286
doi: 10.33594/000000572
doi:

Substances chimiques

Anion Exchange Protein 1, Erythrocyte 0
Ankyrins 0
Annexin A5 0
Environmental Pollutants 0
Membrane Proteins 0
Phosphatidylserines 0
Phospholipids 0
Sulfates 0
Mercury FXS1BY2PGL
Cysteine K848JZ4886

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

500-513

Subventions

Organisme : Fondation SRTS-VD (Service Régional de Transfusion Sanguine - Vaud)
Pays : Switzerland

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Rosaria Notariale (R)

Department of Precision Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Emmanuel Längst (E)

Laboratoire de Recherche sur les Produits Sanguins, Innovation et Produits Thérapeutiques, Transfusion Interrégionale CRS, Epalinges, Switzerland.

Pasquale Perrone (P)

Department of Precision Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

David Crettaz (D)

Laboratoire de Recherche sur les Produits Sanguins, Innovation et Produits Thérapeutiques, Transfusion Interrégionale CRS, Epalinges, Switzerland.

Michel Prudent (M)

Laboratoire de Recherche sur les Produits Sanguins, Innovation et Produits Thérapeutiques, Transfusion Interrégionale CRS, Epalinges, Switzerland, michel.prudent@itransfusion.ch.
Center for Research and Innovation in Clinical Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland, University Hospital and University of Lausanne, Lausanne, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.

Caterina Manna (C)

Department of Precision Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy, caterina.manna@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH